Olema Pharmaceuticals SG&A Expense (Semi Annual) Trends

Olema Pharmaceuticals, Inc. (OLMA)

15.06 -0.06 (-0.40%) USD | NASDAQ | Apr 02, 16:00

15.23 +0.17 (+1.13%) After-Hours: 07:01

View SG&A Expense (Semi Annual) for OLMA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

EyePoint Plc	--
CytomX Therapeutics, Inc.	--
Corvus Pharmaceuticals, Inc.	--
Protagonist Therapeutics, Inc.	--
Oric Pharmaceuticals, Inc.	--